Abstract
2-Aminobenzimidazole (ABZ) and guanidine have immunomodulatory activity, whereas NSAIDs have anti-inflammatory activity. We, therefore, developed several novel ABZ-NSAID conjugate compounds and tested their anti-inflammatory and immunomodulatory activities. We also measured their antioxidant and ulcerogenic properties. We found that all compounds had not only anti-inflammatory activity but they also had immunomodulatory and antioxidant activities. While compound 2 had immunostimulatory activity (humoral antibody titre, HAT 7.2 ± 0.20 and carbon clearance index, K 0.030 ± 0.001), compound 9 had immunosuppressive activity (HAT 3.4 ± 0.24 and K 0.012 ± 0.002). These two compounds did not produce ulcers and hence were safe to the gastric mucosa. In addition, we used Lipinski’s parameters and found that all compounds had drug-like properties. Thus, we have provided new evidences to use compounds 2 and 9 for the treatment of inflammatory and immunomodulatory disorders like rheumatoid arthritis, ulcerative colitis, multiple sclerosis, osteoarthritis and cancer.
Similar content being viewed by others
References
Achar KCS, Hosaman KM, Seetharamareddy HR (2010) In-vivo analgesic and anti-inflammatory activities of newly synthesized benzimidazole derivatives. Eur J Med Chem 45:2048–2054
Aebi H (1974) Catalase. In: Bergmeyer H (ed) Methods of enzymatic analysis, vol 2. Chemic Academic Press Inc. Verlag, New York, pp 673–685
Chen Q, Tian W, Han G, Qi J, Zheng C, Zhou Y, Ding L, Zhao J, Zhu J, Lv J, Sheng C (2013) Design and synthesis of novel benzoheterocyclic derivatives as human acrosin inhibitors by scaffold hopping. Eur J Med Chem 59:176–182
Cho JY (2007) Immunomodulatory effects of NSAIDs at clinically available doses. Arch Pharm Res 30:64–74
Chu D, Kovacs BA (1977) Anti-inflammatory activity in oak gall extracts. Arch Int Pharmacodyn Ther 230:166–176
Cioli V, Putzolu S, Rossi V, Barcellona PS, Corradino C (1979) The role of direct tissue contact in the production of gastrointestinal ulcers by anti-inflammatory drugs in rat. Toxicol Appl Pharmacol 50:283–289
Cook BN, Bentzien J, White A, Nemoto PA, Wang J, Man CC, Soleymanzadeh F, Khine HH, Kashem MA, Kugler SZ, Wolak JP, Roth GP, De Lombaert S, Pullen SS, Takahashi H (2009) Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug design. Bioorg Med Chem Lett 19:773–777
Ellman GL (1959) Tissue sulfhydryl group. Arch Biochem Biophys 82:70–77
Greenhill JV, Lue P (1993) 5-Amidines and guanidines in medicinal chemistry. In: Ellis GP, Luscombe DK (eds) Progress in medicinal chemistry, vol 30. Elsevier B.V, New York, pp 203–326
Hamley P, Tinker AC (1995) 1,2-Diaminobenzimidazoles: selective inhibitor of nitric oxide synthase derived from aminoguanidine. Bioorg Med Chem Lett 5:1573–1576
Hayes ME, Wallace GA, Grongsaard P, Bischoff A, George DM, Michael WM, McPherson J, Stoffel RH, Green DW, Roth GP (2008) Discovery of small molecule benzimidazole antagonists of the chemokine receptor CXCR3. Bioorg Med Chem Lett 18:1573–1576
Jarrahpour A, Motamedifar M, Zarei M, Youssoufi MH, Mimouni M, Chohan ZH, Hadda TB, Petra AP (2010) Osiris and molinspiration together as a guide in drug design: predictions and correlation structure/antibacterial activity relationships of new N-sulfonyl monocyclic β-lactams (part II). Phosphorus Sulfur Silicon Relat Elem 185:491–497
Jarrahpour A, Fathi J, Mimouni M, Hadda TB, Sheikh J, Chohan ZH, Petra AP (2011) Osiris and molinspiration (POM) together as a successful support in drug design: antibacterial activity and biopharmaceutical characterization of some azo schiff bases. Med Chem Res 19:1–7
Jayathirtha MG, Mishra SH (2004) Preliminary immunomodulatory activities of methanol extracts of Eclipta alba and Centella asiatica. Phytomedicine 11:361–365
Kathleen A, Jurenka JS (2003) Inflammatory bowel disease part I: ulcerative colitis—pathophysiology and conventional and alternative treatment options. Altern Med Rev 3:247–283
Kim RM, Chang J, Lins AR, Brady E, Candelore MR, Yang QD, Ding V, Dragovic J, Iliff S, Jiang G, Mock S, Qureshi S, Saperstein R, Szalkowski D, Tamvakopoulos C, Tota L, Wright M, Yang X, Tata JR, Chapman K, Zhang BB, Parmee ER (2008) Discovery of potent, orally active benzimidazole glucagon receptor antagonists. Bioorg Med Chem Lett 18:3701–3705
Koji T, Hirokazu T, Yoshiko K, Izumi T (1998) The effects of nonsteroidal anti-inflammatory drugs on immune functions of human peripheral blood mononuclear cells. Immunopharmacology 40:209–217
Krensky AM, Flavio V, Bennett WM (2006) Immunosuppresants, tolerogens and immunostimulants. In: Brunton LL, Lazo JS, Parker KL (eds) Goodman and Gilman’s the pharmacological basis of therapeutics, 11th edn. McGraw Hill, New York, pp 1405–1428
Leonard NL, Daviy CY, Karl BM (1947) Sulfonate salts of substituted benzimidazoles. J Med Chem 69:2459–2461
Li YF, Wang GF, Luo Y, Huang WG, Tang W, Feng CL, Shi L, Ren Y, Zuo J, Lu W (2007) Identification of 1-isopropylsulfonyl-2-amine benzimidazoles as a new class of inhibitors of hepatitis B virus. Eur J Med Chem 42:1358–1364
Lipinski CA, Lombardo F, Dominy BW, Feeney P (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. J Adv Drug Deliv Rev 46:3–26. Calculation of molecular properties and bioactivity score was done by software. http://www.molinspiration.com
Lo HY, Bentzien J, Fleck RW, Pullen SS, Khine HH, Woska JR, Kugler SZ, Kashem MA, Takahashi H (2008) 2-Aminobenzimidazoles as potent ITK antagonists: trans-stilbene-like moieties targeting the kinase specificity pocket. Bioorg Med Chem Lett 18:6218–6221
Luck HI, Nussenzweig RS (1969) Plasmodium chabaudi and Plasmodiom vinckei: phagocytic activity of mouse reticuloendothelial system. Exp Parasitol 25:319–323
Mavrova AT, Wesselinova D, Vassilev N, Tsenov JA (2013) Design, synthesis and antiproliferative properties of some new 5-substituted-2-iminobenzimidazole derivatives. Eur J Med Chem 63:696–701
Mcinnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205–2219
Mishra A, Veerasamy R, Jain PK, Dixit VK, Agrawal RK (2008) Synthesis, characterization and pharmacological evaluation of amide prodrugs of flurbiprofen. J Braz Chem Soc 19:89–100
Mor M, Bordi F, Silva C, Rivara S, Zuliani V, Vacondio F, Rivara M, Barocelli E, Bertoni S, Ballabeni V, Magnanini F, Impicciatore M, Plazzi PV (2004) Synthesis, biological activity, QSAR and QSPR study of 2-aminobenzimidazole derivatives as potent H3-antagonists. Bioorg Med Chem 12:663–674
Nawrocka W, Sztuba B, Kowalska MW, Liszkiewicz H, Wietrzyk J, Nasulewicz A, Pełczyńska M, Opolski A (2004) Synthesis and antiproliferative activity in vitro of 2-aminobenzimidazole derivatives. Farmaco 59:83–91
Ohkawa H, Ohishi N, Yagi K (1979) Assay of lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358
Ohshika Y (1988) Immunomodulating capacity of the monocyte–macrophage system in patients with uterine cervical cancer. Nippon Sanka Fujinka Gakkai Zasshi 40:601–608
Puri A, Saxena R, Saxena KC, Tandon JS (1994) Immunostimulant activity of Nyctanthes arbor-tristis L. J Ethnopharmacol 42:31–37
Sellin JH, Pasricha PJ (2006) Pharmacotherapy of inflammatory bowel disease. In: Brunton LL, Lazo JS, Parker KL (eds) Goodman and Gilman’s the pharmacological basis of therapeutics, 11th edn. McGraw Hill, New York, pp 1012–1014
Settimo AD, Marini AM, Primofiore G, Subissi A (1991) Synthesis and antihypertensive activity of some 2-aminobenzimidazole and indole derivatives. Farmaco 46:357–367
Sondhi SM, Rajvanshi S, Johar M, Bharti N, Azam A, Singh AK (2002) Anti-inflammatory, analgesic and antiamoebic activity evaluation of pyrimido[1,6-a]benzimidazole derivatives synthesized by the reaction of ketoisothiocyanates with mono and diamines. Eur J Med Chem 37:835–843
Spain RI, Cameron MH, Bourdette D (2009) Recent developments in multiple sclerosis therapeutics. BMC Med 7:74
Volin MV, Koch AE (2011) Interleukin-18: a mediator of inflammation and angiogenesis in rheumatoid arthritis. J Interferon Cytokine Res 31:745–751
Winter CA (1962) Carrageenan-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 111:544–547
Zhang G, Ren P, Gray NS, Sim T, Wang X, Liu Y, Che J, Dong W, Mark SST, Sandberg L, Spalding TA, Romeo R, Iskandar M, Wang Z, Seidel HM, Karanewsky DS, He Y (2009) Discovery of pyrimidine benzimidazoles as Src-family selective Lck inhibitors. Part II. Bioorg Med Chem Lett 19:6691–6695
Zhang Z, Ojo KK, Johnson SM, Larson ET, Geiger PHJA, Gonzalez AC, White AC, Parsons M, Merritt EA, Maly DJ, Verlinde CLMJ, Voorhis WCV, Fan E (2012) Benzoylbenzimidazole-based selective inhibitors targeting Cryptosporidium parvum and Toxoplasma gondii calcium-dependent protein kinase-1. Bioorg Med Chem Lett 22:5264–5267
Acknowledgments
The authors are thankful to Crystal Pharmaceuticals (Ambala, India), FDC India Ltd (Mumbai, India), Ranbaxy Research Laboratories (Gurgaon, India) and Dr. Reddy’s Research Laboratory (Hyderabad, India) for providing the NSAIDS and other drugs as generous gift samples.
Conflict of interest
There are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bansal, Y., Silakari, O. 2-Aminobenzimidazole conjugates of NSAIDS: novel compounds with immunomodulatory, anti-inflammatory and antioxidant actions. Med Chem Res 24, 1170–1179 (2015). https://doi.org/10.1007/s00044-014-1198-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-014-1198-3